IRF9 and liver cancer: While interferon stimulating gene IRF9 is a key factor forcing the anti-proliferative effect of IFN-α, ISG15 is involved in a Wnt/beta-catenin suppressing pathway and may inhibit liver cancer cell growth [29–32].